China Resources Double-Crane Pharmaceutical Co Ltd (600062) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China.
Total Assets Chart for China Resources Double-Crane Pharmaceutical Co Ltd
China Resources Double-Crane Pharmaceutical Co Ltd (600062) total assets for FY2025 were CNY 17.0B, a 1.9% change from FY2024. China Resources Double-Crane Pharmaceutical Co Ltd's total assets grew from CNY 131.3M in 1994 to CNY 17.0B in 2025 (12851.1% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 6.5%, 10-year CAGR of 8.2%, 20-year CAGR of 7.8%.
Total Assets (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥16.75B
- Implied Share Price
- ¥16.13
- Enterprise Value
- ¥15.26B
- Revenue (TTM)
- ¥10.73B
- EBITDA
- ¥2.41B
- Profit Margin
- 15.15%
- Trailing P/E
- 10.34
- Forward P/E
- 12.35
- Price/Book (MRQ)
- 1.37
- Price/Sales (TTM)
- 1.56
- EV/EBITDA
- 5.78
- EV/Revenue
- 1.41
- Dividend Yield
- 0.00%
- Book Value
- ¥11.26
- Free Cash Flow (FY2025)
- ¥869.88M
- Free Cash Flow Yield
- 5.19%
Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.